(5alpha,6alpha)-17-methyl-3-{2-[(1-methylethyl)amino]ethoxy}-7,8-didehydro-4,5-epoxymorphinan-6-ol (61273-46-9)

Identification
Name:	(5alpha,6alpha)-17-methyl-3-{2-[(1-methylethyl)amino]ethoxy}-7,8-didehydro-4,5-epoxymorphinan-6-ol
Synonyms:	61273-46-9
CAS:	61273-46-9
Molecular Formula:	C₂₂H₃₀N₂O₃
Molecular Weight:	370.4852
InChI:	InChI=1/C22H30N2O3/c1-13(2)23-9-11-26-18-7-4-14-12-16-15-5-6-17(25)21-22(15,8-10-24(16)3)19(14)20(18)27-21/h4-7,13,15-17,21,23,25H,8-12H2,1-3H3/t15-,16+,17-,21-,22-/m0/s1
Molecular Structure:
Properties
Flash Point:	276.2°C
Boiling Point:	533°C at 760 mmHg
Density:	1.25g/cm³
Refractive index:	1.629
Flash Point:	276.2°C
Safety Data

Other Product

(5alpha,6alpha)-6-bromo-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3-ol
(5alpha,6alpha)-17-methyl-3-(2-morpholin-4-ylethoxy)-4,5-epoxymorphinan-6-ol
(5alpha,6alpha)-17-methyl-3-(2-morpholin-4-ylethoxy)-7,8-didehydro-4,5-epoxymorphinan-6-yl acetate bis(2,3-dihydroxybutanedioate) (salt)
(5alpha,6alpha)-3-hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-yl acetate hydrochloride
(5alpha,6alpha)-3-hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-yl butanoate
(5alpha,6alpha)-3-hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-yl propanoate hydrochloride
(5alpha,6alpha)-6-hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3-yl acetate
(5alpha,6alpha)-3-hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-yl dihydrogen phosphate
(5alpha,6alpha)-6-hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3-yl dihydrogen phosphate
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-17-methyl-3-(2-(4-morpholinyl)ethoxy)-, (5alpha,6alpha)-, mixt. with (R*,S*)-(+-)-alpha-(1-aminoethyl)benzenemethanol and N-(4-hydroxyphenyl)acetamide
(5alpha,8alpha)-3-methoxy-17-methyl-6,7-didehydro-4,5-epoxymorphinan-8-ol hydrochloride
(5alpha,6alpha)-17-methyl-3-(2-morpholin-4-ylethoxy)-4,5-epoxymorphinan-6-yl acetate bis(2,3-dihydroxybutanedioate) (salt)
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid and N-(4-ethoxyphenyl)acetamide
(5alpha,6beta)-3-methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-ol 2,3-dihydroxybutanedioate (salt)
3-methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-ol - 4-(1-hydroxy-1-methylethyl)-1-methylcyclohexanol (1:1)
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-17-methyl-3-(2-(4-morpholinyl)ethoxy)-, (5alpha,6alpha)-, mixt. with gamma-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine (Z)-2-butenedioate (1:1), 3-(2-methoxyphenoxy)-1,2-propanediol and 2,2-methylenebis(4-chloro-3-methyl-6-(1-methylethyl)phenol)
(5alpha)-3-methoxy-17-methyl-6-oxo-7,8-didehydro-4,5-epoxymorphinan-14-yl (2E)-but-2-enoate
(5alpha,8alpha)-3-methoxy-17-methyl-4,5-epoxymorphinan-8-ol
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, hydrochloride, (5alpha,6alpha)-, mixt. with (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2,4))non-7-yl alpha-(hydroxymethyl)benzeneacetate hydrobromide and sodium (1S)-7,7-dimethyl-2-oxobicyclo(2.2.1)heptane-1-methane sulfonate
(5alpha,6beta)-6-methoxy-17-methyl-4,5-epoxymorphinan-3-ol